Today’s Hot List: Aratana Therapeutics, Inc. (NASDAQ:PETX), Agenus Inc. (NASDAQ:AGEN), Palo Alto Networks, Inc. (NYSE:PANW), ION Geophysical Corporation (NYSE:IO), DexCom, Inc. (NASDAQ:DXCM)

On 6 August, Aratana Therapeutics, Inc. (NASDAQ:PETX) announced its second quarter 2015 financial results and product updates. For the quarter ended June 30, 2015, Aratana reported a net loss of $(8.0) million, or $(0.23) basic loss per share and $83.6 million in cash, cash equivalents and short-term investments. Aratana Therapeutics, Inc. (NASDAQ:PETX) belongs to Healthcare sector. Its weekly performance is -3.29%. On last trading day company shares ended up $17.04. Aratana Therapeutics, Inc. (NASDAQ:PETX) distance from 50-day simple moving average (SMA50) is 8.58%.

Agenus Inc. (NASDAQ:AGEN) said it has acquired rights from Diatheva for antibodies targeting carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1). The deal could generate up to $44 million, plus sales milestones and royalties, for Diatheva. Agenus Inc. (NASDAQ:AGEN) shares fell -2.15% in last trading session and ended the day at $7.73. AGEN return on assets is -98.60%. Agenus Inc. (NASDAQ:AGEN) quarterly performance is 13.01%.

On 5 August, Palo Alto Networks, Inc. (NYSE:PANW) announced the formation of a strategic alliance which will transform the effectiveness, accuracy, and speed by which large, distributed organizations prevent, detect, and respond to cyberthreats. On 07 August, Palo Alto Networks, Inc. (NYSE:PANW) shares advanced 0.59% and was closed at $175.52. PANW EPS growth in last 5 year was -58.00%. Palo Alto Networks, Inc. (NYSE:PANW) year to date (YTD) performance is 43.20%.

ION Geophysical Corporation (NYSE:IO) has announced the availability of fast-track pre-stack time migrated (PSTM) data from the first phase of its MexicoSPAN program. ION Geophysical Corporation (NYSE:IO) ended the last trading day at $0.61. Company weekly volatility is calculated as 13.69% and price to cash ratio as 0.70. ION Geophysical Corporation (NYSE:IO) showed a weekly performance of -22.77%.

DexCom, Inc. (NASDAQ:DXCM) reported a second quarter loss of $0.05 per share after the bell Wednesday, compared to the loss of $0.09 per share last year. Total revenue grew to $93.2 million, an increase of 59% from a year ago. DexCom, Inc. (NASDAQ:DXCM) shares fell -1.66% in last trading session and ended the day at $91.76. DXCM Gross Margin is 67.70% and its return on assets is -13.60%. DexCom, Inc. (NASDAQ:DXCM) quarterly performance is 35.14%.

Leave a Reply

Your email address will not be published. Required fields are marked *